» Articles » PMID: 22009939

Sustained Activation of PPARα by Endogenous Ligands Increases Hepatic Fatty Acid Oxidation and Prevents Obesity in Ob/ob Mice

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2011 Oct 20
PMID 22009939
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity, a major health concern, results from an imbalance between energy intake and expenditure. Leptin-deficient ob/ob mice are paradigmatic of obesity, resulting from excess energy intake and storage. Mice lacking acyl-CoA oxidase 1 (Acox1), the first enzyme of the peroxisomal fatty acid β-oxidation system, are characterized by increased energy expenditure and a lean body phenotype caused by sustained activation of peroxisome proliferator-activated receptor α (PPARα) by endogenous ligands in liver that remain unmetabolized in the absence of Acox1. We generated ob/ob mice deficient in Acox1 (Acox1(-/-)) to determine how the activation of PPARα by endogenous ligands might affect the obesity of ob/ob mice. In contrast to Acox1(-/-) (14.3±1.2 g at 6 mo) and the Acox1-deficient (ob/ob) double-mutant mice (23.8±4.6 g at 6 mo), the ob/ob mice are severely obese (54.3±3.2 g at 6 mo) and had significantly more (P<0.01) epididymal fat content. The resistance of Acox1(-/-)/ob/ob mice to obesity is due to increased PPARα-mediated up-regulation of genes involved in fatty acid oxidation in liver. Activation of PPARα in Acox1-deficient ob/ob mice also reduces serum glucose and insulin (P<0.05) and improves glucose tolerance and insulin sensitivity. Further, PPARα activation reduces hepatic steatosis and increases hepatocellular regenerative response in Acox1(-/-)/ob/ob mice at a more accelerated pace than in mice lacking only Acox1. However, Acox1(-/-)/ob/ob mice manifest hepatic endoplasmic reticulum (ER) stress and also develop hepatocellular carcinomas (8 of 8 mice) similar to those observed in Acox1(-/-) mice (10 of 10 mice), but unlike in ob/ob (0 of 14 mice) and OB/OB (0 of 6 mice) mice, suggesting that superimposed ER stress and PPARα activation contribute to carcinogenesis in a fatty liver. Finally, absence of Acox1 in ob/ob mice can impart resistance to high-fat diet (60% fat)-induced obesity, and their liver had significantly (P<0.01) more cell proliferation. These studies with Acox1(-/-)/ob/ob mice indicate that sustained activation of lipid-sensing nuclear receptor PPARα attenuates obesity and restores glucose homeostasis by ameliorating insulin resistance but increases the risk for liver cancer development, in part related to excess energy combustion.

Citing Articles

Transcriptomics and proteomics characterizing the antioxidant mechanisms of semaglutide in diabetic mice with cognitive impairment.

Yang Y, Song L, Yu L, Zhang J, Zhang B Int J Mol Med. 2025; 55(4).

PMID: 39886945 PMC: 11819768. DOI: 10.3892/ijmm.2025.5497.


Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.

Dey A, Mannan A, Dhiman S, Singh T Psychopharmacology (Berl). 2024; 241(8):1491-1516.

PMID: 38801530 DOI: 10.1007/s00213-024-06617-6.


Hepatocyte-Specific PEX16 Abrogation in Mice Leads to Hepatocyte Proliferation, Alteration of Hepatic Lipid Metabolism, and Resistance to High-Fat Diet (HFD)-Induced Hepatic Steatosis and Obesity.

Chen X, Wang L, Denning K, Mazur A, Xu Y, Wang K Biomedicines. 2024; 12(5).

PMID: 38790950 PMC: 11117803. DOI: 10.3390/biomedicines12050988.


Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD).

Singh S, Kumar A, Gupta S, Agrawal R Tissue Barriers. 2023; 12(3):2289830.

PMID: 38050958 PMC: 11262216. DOI: 10.1080/21688370.2023.2289830.


Mapping novel QTL and fine mapping of previously identified QTL associated with glucose tolerance using the collaborative cross mice.

Abu-Toamih-Atamni H, Lone I, Binenbaum I, Mott R, Pilalis E, Chatziioannou A Mamm Genome. 2023; 35(1):31-55.

PMID: 37978084 DOI: 10.1007/s00335-023-10025-0.


References
1.
Ntambi J, Miyazaki M, Stoehr J, Lan H, Kendziorski C, Yandell B . Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A. 2002; 99(17):11482-6. PMC: 123282. DOI: 10.1073/pnas.132384699. View

2.
Reddy J, Goel S, Nemali M, Carrino J, Laffler T, Reddy M . Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci U S A. 1986; 83(6):1747-51. PMC: 323161. DOI: 10.1073/pnas.83.6.1747. View

3.
Fan C, Pan J, Usuda N, Yeldandi A, Rao M, Reddy J . Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem. 1998; 273(25):15639-45. DOI: 10.1074/jbc.273.25.15639. View

4.
Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, Yamano S . Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 2008; 7(4):302-11. PMC: 2587176. DOI: 10.1016/j.cmet.2008.03.003. View

5.
Chen H, Dardik B, Qiu L, Ren X, Caplan S, Burkey B . Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys. Endocrinology. 2010; 151(7):3115-24. DOI: 10.1210/en.2009-1366. View